Since its founding in 1999, NuVant has been conducting research and development in portable fuel cell technology. NuVant has patents in intermediate fuel cell electrolytes and in electrode component testing instrumentation. NuVant was first to develop and patent array electrochemical reactors for high throughput evaluation of electrode components for energy conversion and storage devices. Their strategy for high throughput characterization of electrode components is a common counter/reference electrode and a segmented array working-electrode. High precision is enabled by elimination of performance variations at the counter electrode typical of single cell systems.
NuVant offers an Arraystat potentiostat that enables simultaneous evaluation of all electrodes or row-by-row evaluation of electrodes to mitigate reactant depletion when operating at low reactant stoichiometric ratios. The Array Fuel Cell, coupled with the Arraystat, enables evaluation of electrode components under actual fuel cell operating conditions. The Arraystat is also used by researchers worldwide to evaluate photoelectrochemical catalysts. In 2009, NuVant expanded its product line to include low cost, high performance potentiostat/galvanostats including the EZstat and Powerstat series, which control fuel cell test stands, pumps, mass flow controllers and more. NuVant is a one-stop shopping resource for electrode fabrication, including a recently introduced heated vacuum table for membrane-electrode-assembly (MEA) preparation (MEA fabrication is taught from an accompanying DVD, or a hands-on MEA short course offered twice yearly), ELAT gas diffusion layers and polymer electrolytes. NuVant has established a high-throughput electrode characterization facility that provides electrode characterization services.
 |
NuVant has established a Concept to Market (CTM) department to provide rapid prototyping services. In addition to fleshing out circuit designs, CTM tests circuit design components prior to generating a final CAD layout of the board. CTM procures and |
|